Institutional outbreak involving multiple clades of IMP-producing Enterobacter cloacae complex sequence type 78 at a cancer center in Tokyo, Japan
Sohei Harada(University of Tokyo Hospital), Brian Hayama(Japanese Foundation For Cancer Research), Koh Okamoto(Rush University Medical Center), Keito Ida(Japanese Foundation For Cancer Research), Kazumi Takehana(Japanese Foundation For Cancer Research), Daisuke Ohkushi(Japanese Foundation For Cancer Research), Daigo Shoji(Japanese Foundation For Cancer Research), Kotaro Aoki(Toho University), Tomomi Akatsuchi(Japanese Foundation For Cancer Research), Kyoji Moriya(The University of Tokyo), Yoshikazu Ishii(Toho University), Yohei Doi(Fujita Health University)
Cited by 16
Related Papers
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
|The Lancet Infectious Diseases|2017|521
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study
|The Lancet Infectious Diseases|2021|338
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study
|The Lancet Infectious Diseases|2020|328
Virologic Analysis of Non‐B, Non‐C Hepatocellular Carcinoma in Japan: Frequent Involvement of Hepatitis B Virus
|The Journal of Infectious Diseases|2000|99
Hepatitis B virus genotypes and hepatocellular carcinoma in Japan
|Gastroenterology|2001|97